Bourse

26 Jan 2021

Vif succès de l’introduction en bourse de MEDESIS PHARMA, société de biotechnologie pharmaceutique, sur Euronext Growth Paris® (ISIN : FR0010844464, MNEMO : ALMDP).

Retrouver l’intégralité des informations sur la nouvelle page Bourse

ACCUEIL MENTIONS LÉGALES POLITIQUE DE CONFIDENTIALITÉ CONTACT

Site propulsé par Lucas Belpassi Développeur Web

Manage Cookie Consent

We use cookies to optimize our website and our service. Cookie Policy

Functional Functional Toujours activé

The storage or technical access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication on an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Marketing Marketing

The technical storage or access that is used exclusively for statistical purposes. Technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance by your ISP, or additional third-party records, information stored or retrieved for this purpose alone generally cannot be used to identify you.

Marketing Marketing

Storage or technical access is required to create user profiles to send advertising, or to track the user across one or multiple websites for similar marketing purposes.

Personalize

{title} {title} {title}